Related Experiment Video
Updated: Jul 14, 2026

Breath Collection from Children for Disease Biomarker Discovery
Published on: February 14, 2019
Are exhaled breath condensates useful in monitoring asthma?
Fanny W S Ko1, T F Leung, David S C Hui
1Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, New Territories, Hong Kong. fannyko@cuhk.edu.hk
Abstract:
Exhaled breath condensate (EBC) has emerged as a novel noninvasive technique for assessment of airway inflammation, and it also provides useful information on the airway lining fluid composition. Examples of markers that can be identified in the EBC of patients with asthma include pH, eicosanoids, nitrogen oxides and related products, markers of oxidative stress, certain cytokines, chemokines, and growth factors. There is some evidence that certain markers in EBC differ between patients with asthma and controls, and some markers may correlate with asthma severity and lung function, but there are many methodologic pitfalls with EBC assessment that limit its clinical applicability at present. More studies are needed before this technique can be recommended for clinical use.
Related Concept Videos
Inhaled Medications
Asthma III: Clinical Manifestations
Breathing
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
COPD: Management Using Bronchodilators and Corticosteroids

